CNS Pharmaceuticals Inc (CNSP)
0.216
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
0.219
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Total Liabilities (Quarterly): 6.091M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.091M |
| December 31, 2023 | 6.133M |
| September 30, 2023 | 4.069M |
| June 30, 2023 | 3.997M |
| March 31, 2023 | 3.923M |
| December 31, 2022 | 4.920M |
| September 30, 2022 | 1.244M |
| June 30, 2022 | 0.9239M |
| March 31, 2022 | 1.069M |
| December 31, 2021 | 2.594M |
| September 30, 2021 | 2.407M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.831M |
| March 31, 2021 | 1.902M |
| December 31, 2020 | 1.905M |
| September 30, 2020 | 0.5108M |
| June 30, 2020 | 0.2612M |
| March 31, 2020 | 0.336M |
| December 31, 2019 | 0.311M |
| September 30, 2019 | 1.398M |
| June 30, 2019 | 1.264M |
| December 31, 2018 | 1.233M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2612M
Minimum
Jun 2020
6.133M
Maximum
Dec 2023
2.355M
Average
1.866M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.661M |
| Shareholders Equity (Quarterly) | -4.430M |